Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Sep 3, 2014

Why Is Everybody Picking on Sovaldi?

It is highly cost-effective at the $84,000 price, but....

Why Is Everybody Picking on Sovaldi?

A reduction in price for the HCV drug could open up the potential market and increase dollar sales above those anticipated for the present price. [© ZIQUIU - Fotolia.com]

  • For those infected with hepatitis C virus (HCV), the new drug Sovaldi seems like a godsend. As one part of a triple-drug therapy, it ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »